loading
前日終値:
$17.51
開ける:
$17.51
24時間の取引高:
27,211
Relative Volume:
0.97
時価総額:
$6.10B
収益:
$417.75M
当期純損益:
$32.27M
株価収益率:
176.82
EPS:
0.0975
ネットキャッシュフロー:
-
1週間 パフォーマンス:
-3.09%
1か月 パフォーマンス:
-8.78%
6か月 パフォーマンス:
+0.00%
1年 パフォーマンス:
+0.00%
1日の値動き範囲:
Value
$17.24
$17.82
1週間の範囲:
Value
$17.24
$18.66
52週間の値動き範囲:
Value
$14.01
$30.36

Telix Pharmaceuticals Ltd Adr Stock (TLX) Company Profile

Name
名前
Telix Pharmaceuticals Ltd Adr
Name
セクター
Healthcare (1166)
Name
電話
-
Name
住所
-
Name
職員
0
Name
Twitter
Name
次回の収益日
Name
最新のSEC提出書
Name
TLX's Discussions on Twitter

TLX を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
TLX
Telix Pharmaceuticals Ltd Adr
17.24 6.10B 417.75M 32.27M 0 0.0975
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
492.69 131.41B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
637.36 72.26B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
589.15 35.93B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
268.46 34.75B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
267.39 28.24B 3.81B -644.79M -669.77M -6.24

Telix Pharmaceuticals Ltd Adr Stock (TLX) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-11-15 開始されました UBS Buy

Telix Pharmaceuticals Ltd Adr (TLX) 最新ニュース

pulisher
Mar 21, 2025

FDA Green Lights Revolutionary Prostate Cancer Detection Tool: What Makes Gozellix a Game-Changer - StockTitan

Mar 21, 2025
pulisher
Mar 20, 2025

Telix Pharmaceuticals Limited (ASX:TLX) Receives FDA Approval for Gozellix® - The Capital Club

Mar 20, 2025
pulisher
Mar 20, 2025

Paladin Energy Ltd (ASX:PDN) Suspends Operations at Langer Heinrich Mine - The Capital Club

Mar 20, 2025
pulisher
Mar 17, 2025

Major Breakthrough: First PSMA-PET Imaging Agent Approved in Brazil's $330M Market - StockTitan

Mar 17, 2025
pulisher
Mar 12, 2025

Telix's Game-Changing Isotope Technology Revolutionizes Cancer Treatment Production - StockTitan

Mar 12, 2025
pulisher
Mar 03, 2025

Can Telix's Cancer Therapies Transform Urology Treatment? Top Oncologists Weigh In - StockTitan

Mar 03, 2025
pulisher
Feb 25, 2025

Could This New Kidney Cancer Imaging Tool Transform Diagnosis? FDA Fast-Tracks Review - StockTitan

Feb 25, 2025
pulisher
Feb 25, 2025

Could This New Prostate Cancer Treatment Change Patient Outcomes? Miami Trial Now Recruiting - StockTitan

Feb 25, 2025
pulisher
Feb 21, 2025

Telix Pharmaceuticals Ltd (TLPPF) (FY 2024) Earnings Call Highlights: Record Revenue Growth and ... By GuruFocus - Investing.com Canada

Feb 21, 2025
pulisher
Feb 20, 2025

Can Telix's Triple Product Launch in 2025 Justify Its Bold $1.2B Revenue Target? - StockTitan

Feb 20, 2025
pulisher
Feb 13, 2025

Clinical Trial Success: Telix's Revolutionary Prostate Cancer Treatment Shows Promising Results - StockTitan

Feb 13, 2025
pulisher
Feb 12, 2025

Major Breakthrough: Revolutionary Prostate Cancer Detection Tool Gets UK Green Light - StockTitan

Feb 12, 2025
pulisher
Jan 30, 2025

Telix Pharmaceuticals acquires ImaginAb assets and technology - Investing.com

Jan 30, 2025
pulisher
Jan 30, 2025

Telix Completes Acquisition of Next-Generation Therapeutic Assets and Innovative Biologics Technology Platform - GlobeNewswire Inc.

Jan 30, 2025
pulisher
Jan 27, 2025

Telix Pharmaceuticals Acquires RLS USA in Major $230M Radiopharmacy Network Deal - StockTitan

Jan 27, 2025
pulisher
Jan 22, 2025

ImaginAb Sells Therapeutic Pipeline to Telix Pharmaceuticals, Focuses on CD8 ImmunoPET Development - StockTitan

Jan 22, 2025
pulisher
Jan 13, 2025

Telix Pharmaceuticals Hits Record $517M Revenue, Up 55% as Cancer Imaging Portfolio Expands - StockTitan

Jan 13, 2025
pulisher
Jan 12, 2025

Telix Pharmaceuticals Acquires ImaginAb's Cancer Drug Pipeline in $45M Strategic Deal - StockTitan

Jan 12, 2025
pulisher
Jan 08, 2025

ASX December health sector winners… and a 91pc drop for a trial-flopped stock - Stockhead

Jan 08, 2025
pulisher
Dec 31, 2024

ASX healthcare 2024 winners and losers, plus what’s next for 2025 - Stockhead

Dec 31, 2024
pulisher
Dec 03, 2024

Clayton Utz M&A partner Niro Ananda set to resign; KWM eyed - The Australian Financial Review

Dec 03, 2024
pulisher
Nov 27, 2024

Health Check: ASX sleep company emerges from slumber with a revenue and earnings upgrade - Stockhead

Nov 27, 2024
pulisher
Nov 15, 2024

UBS bullish on Telix stock—Illuccix growth & therapeutic expansion fuel upside - Investing.com

Nov 15, 2024
pulisher
Nov 14, 2024

Key Investors Say Bet on These Stocks at Sohn Australia Conference - BNN Bloomberg

Nov 14, 2024
pulisher
Nov 13, 2024

TLXTelix Pharmaceuticals Ltd ADR Latest Stock News & Market Updates - StockTitan

Nov 13, 2024
pulisher
Nov 13, 2024

Telix Pharmaceuticals Debuts on Nasdaq Global Select Market Under TLX Symbol - StockTitan

Nov 13, 2024
pulisher
Oct 29, 2024

Liverpool Partners, Adamantem seek new owner for Plena Healthcare - The Australian Financial Review

Oct 29, 2024
pulisher
Oct 22, 2024

Telix spins off radiopharma unit to form Rhine Pharma | Pharmaceutical | The Pharmaletter - The Pharma Letter

Oct 22, 2024
pulisher
Oct 18, 2024

Guess which top 100 ASX stock is venturing off to the Nasdaq - The Motley Fool Australia

Oct 18, 2024
pulisher
Oct 17, 2024

Telix Files Form 20-F Registration Statement for Nasdaq ADS - Yahoo Finance

Oct 17, 2024
pulisher
Jul 16, 2024

Up 66% in FY24, will Telix Pharmaceuticals shares continue? - The Motley Fool Australia

Jul 16, 2024
pulisher
Jun 14, 2024

TLX ASX: Telix pulls $300m Nasdaq IPO as investors demand deep discount - The Australian Financial Review

Jun 14, 2024
pulisher
Jun 05, 2024

Radiopharma-focused Telix heats up IPO summer market with $200M offering - Fierce Biotech

Jun 05, 2024
pulisher
Feb 27, 2024

Telix Pharmaceuticals to Acquire IsoTherapeutics Group - Contract Pharma

Feb 27, 2024
pulisher
Jan 31, 2024

Pharmaceutical Industry Mergers & Acquisitions Roundup - Contract Pharma

Jan 31, 2024
pulisher
Jan 05, 2024

Australia's Telix Pharmaceuticals jumps on potential US listing - Reuters.com

Jan 05, 2024
pulisher
Nov 03, 2022

Check Up: These 4 ASX healthcare stocks come with Strong Buy recommendations - Stockhead

Nov 03, 2022
pulisher
Mar 01, 2016

Queen's University Leads Irish Trial of New Prostate Cancer Treatment - Imaging Technology News

Mar 01, 2016
pulisher
Oct 13, 2012

Morningstar | Empowering Investor Success - Morningstar

Oct 13, 2012

Telix Pharmaceuticals Ltd Adr (TLX) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$77.99
price up icon 0.39%
$306.97
price down icon 0.34%
$31.37
price down icon 0.88%
$20.32
price down icon 1.36%
$94.95
price down icon 0.47%
biotechnology ONC
$267.39
price up icon 1.82%
大文字化:     |  ボリューム (24 時間):